Medicine

The drug, called Palforzia, was developed by California startup Aimmune Therapeutics to be taken daily in a regimen known as oral immunotherapy.

Instead of paying doctors piecemeal for prenatal appointments and delivery of the baby, some insurers now offer medical practices one lump sum to cover it all.

House Speaker Nancy Pelosi unveiled her sweeping plan to reduce drug prices Thursday, which included an international price index.

Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection Sunday night

Physician David Fajgenbaum discusses his new memoir about his struggle with a rare and fatal disease and his search to understand and cure it.

A geriatrician's lawsuit has New Jersey's aid in dying law on hold. It's part of a long fight over similar laws across the country.

An Oklahoma judge found Johnson & Johnson and its subsidiaries helped fuel the opioid crisis and ordered the consumer products giant to pay $572M to clean up the problem.

Weight Watchers new app for kids has been criticized for possibly harming users self-esteem. We'll talk about how to teach kids healthy habits and a positive body image.

Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis.

People with drug-resistant tuberculosis take many pills over a long period of time. Cure rate is low.

Doctors warn of poor health and rising costs they say will come from sweeping Trump administration changes that would deny green cards to many immigrants who use Medicaid.

Renee Bach founded a charity that went on to care for over 900 severely malnourished babies and children. Now she is being sued by two of the mothers whose children died.

In a letter Friday, the dean of the medical college said those who applied for tuition remission can still collect it for themselves and their dependents.

Globally, antibiotic-resistant bacteria are becoming an increasing problem. The Wistar Institute convened researchers to discuss alternative treatments.

It weakens an import ban that has stood as a symbol of the political clout of the pharmaceutical industry.